Genome edited animals are important in the study of a whole host of scientific fields. Now new research published in BMC Biotechnology takes a novel method for genome editing in mice and successfully applies it to rats, another important animal model. Here, the authors of this study highlight the functional and ethical benefits of this new method.
Monthly Archives: April 2018
Research published today in BMC Public Health, which looked at vaccine-related behaviors in California over a 14 year period, finds that non-medical vaccine exemptions operate in a similar way to a contagious disease with cases emanating from high exemption areas. Here, author for the research, Paul L Delamater, tells us about the findings and what they mean in relation to vaccination policies.
Drug dependence is a major public health crisis. The main goal of treating substance dependence is to prevent relapse. In clinical practice, the risk of relapse remains high even after completion of treatment and prolonged abstinence. Our study published in BMC Neuroscience aims to understand the vulnerability to relapse as it is crucial for the development of an effective treatment for drug addiction.
BMC Veterinary Research and BMC Microbiology are delighted to announce the launch of a joint thematic series on ‘Veterinary Antimicrobial Resistance and Antimicrobial Use’ and its associated ‘Call for papers’. Editors Dr. Hayley Henderson and Dr. Cecilia Devoto talk more about the ideas behind the series.
Mexican cavefish populations are used by researchers as models to study adaptations to environmental changes. Now, new research published in BMC Evolutionary Biology suggests that the origin of these cavefish populations is potentially as recent as 20,000 years ago, going against widely held assumptions that these populations have a very ancient origin.
In honor of Parkinson’s Awareness Week, we are sharing the new and exciting discoveries in Parkinson’s disease treatment. Drs. Han-Lin Chiang and Yih-Ru Wu, leaders in Parkinson’s disease research, discuss some of the most promising advancements in the treatment of Parkinson’s disease.
Precision targeting offers hope after a life-changing cancer diagnosis. However, some cancers that initially respond to targeted chemotherapy become treatment-resistant — and this may have nothing to do with the drug itself. Hidden layers of regulation that control the activity of genes can produce drug-resistant, surviving cells. New research, published today in BMC Systems Biology helps explain how therapy-resistant cancers arise — findings with important implications for the future of cancer therapy.